CKD Bio Corp.
KSC: 063160.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Wan-Kap Park
- Employees
- 519
- Headquarters
- Seoul, South Korea
- IPO year
- 2000
- Market cap
- ₩105.5B
- Website
- https://www.ckdbio.com
Loading 063160…
Loading profile data…Frequently asked questions about 063160
What does CKD Bio Corp. (063160.KS) do?
CKD Bio Corp. manufactures and distributes drug substances based on fermentation, synthesis, and biotechnology in South Korea. It offers drug substances in the areas of antibiotic, ß-lactamase inhibitors, immunosuppressants, anticancer drugs, obesity treatment drugs, dry eye, antivirus, antituberculosis, antihyperlipidemics, and probiotics. The...
Where does 063160.KS trade?
CKD Bio Corp. (063160.KS) trades on the Korea Exchange.
What sector is 063160.KS in?
CKD Bio Corp. (063160.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of CKD Bio Corp.?
Wan-Kap Park is the chief executive officer of CKD Bio Corp. (063160.KS).
Where is CKD Bio Corp. headquartered?
CKD Bio Corp. is headquartered in South Korea.
Does 063160.KS pay a dividend?
Yes — CKD Bio Corp. (063160.KS) paid a trailing twelve-month dividend of KRW 100.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 063160.KS go public?
CKD Bio Corp. (063160.KS) completed its initial public offering in 2000.